Pricing Log in Create free account

Imunon, Inc. (IMNN) vs Skye Bioscience, Inc. (SKYE)

Imunon, Inc. and Skye Bioscience, Inc. are both Biotechnology companies. Imunon, Inc. and Skye Bioscience, Inc. are of similar size ($5.1M and $4.6M). Across the 12 metrics below, Imunon, Inc. leads on 6 and Skye Bioscience, Inc. on 6.

Valuation

Metric IMNN SKYE Biotechnology median
P/E n/m n/m 10.60
P/S 8.90 16.46 9.40
P/B 2.30 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 6.23 3.61 9.02
Earnings yield (450.59%) (1,026.26%) (32.88%)
Free cash flow yield (341.72%) (779.11%) (23.13%)

Profitability

Metric IMNN SKYE Biotechnology median
Gross margin 0.00% 68.04% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (641.02%) (233.87%) (51.96%)
Return on assets (123.93%) (159.80%) (46.06%)
Return on invested capital (324.37%) 0.00% 0.00%

Growth

Metric IMNN SKYE Biotechnology median
Revenue growth (TTM) 0.00% — 6.76%
EPS growth (last fiscal year) 59.68% (93.15%) 29.88%
Revenue growth, 5-year CAGR 0.00% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMNN SKYE Biotechnology median
Debt to equity 1.32 0.00 0.00
Current ratio 1.82 0.95 4.97
Net debt to EBITDA 0.63 0.45 1.01

Dividend

Metric IMNN SKYE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMNN SKYE Biotechnology median
Market cap 5.05m 4.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack